New drug 'cuts heart attack risk'

A new clot-busting drug approved for use on the NHS cuts the risk of dying after a heart attack.

Brilique (ticagrelor) taken with aspirin is suitable for people who have been admitted to hospital after a heart attack or an episode of unstable angina, according to draft guidance from the National Institute for Health and Clinical Excellence (Nice).